First step towards precision medicine for antithyroid drug-induced agranulocytosis
Journal
The Lancet Diabetes and Endocrinology
Journal Volume
4
Journal Issue
6
Pages
473-474
Date Issued
2016
Author(s)
SDGs
Other Subjects
antithyroid agent; HLA B38 antigen; HLA DRB1 antigen; antithyroid agent; agranulocytosis; allele; antithyroid drug induced agranulocytosis; antithyroid drug induced agranulocytosis; drug induced disease; European; France; genetic susceptibility; genome-wide association study; genotype; Germany; human; Note; personalized medicine; priority journal; single nucleotide polymorphism; Spain; Sweden; agranulocytosis; Graves disease; personalized medicine; Agranulocytosis; Antithyroid Agents; Graves Disease; Humans; Precision Medicine
Publisher
Lancet Publishing Group
Type
note